The Outcomes of Family Haploidentical Hematopoietic Stem Cell Transplantation in Hematologic Malignancies Are Not Associated with Patient Age

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 8, 2011, Pages 1205-1213

  Dong, Lujia ^a   Wu, Tong ^b   Gao, Zhi Yong ^a   Zhang, Mei Jie ^c   Kan, Fangyu ^d   Spellman, Stephen R ^d   Tan, Xi You ^a   Zhao, Yan Li ^b   Wang, Jing Bo ^b   Lu, Dao Pei ^a,b   Miklos, David ^e   Petersdorf, Effie ^f   Fernandez Vina, Marcelo ^g   Lee, Stephanie J ^f  

^a FUDAN UNIVERSITY   (China)

^b Dao Pei Hospital   (China)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d NATIONAL MARROW DONOR PROGRAM   (United States)

^e STANFORD UNIVERSITY   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Antithymocyte globulin; Blood and marrow transplantation; Haploidentical; HLA mismatched; Leukemia

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CHILD; CHINA; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GRAFT VERSUS HOST REACTION; HAPLOIDY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NEWBORN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; SCHOOL CHILD; T CELL DEPLETION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HAPLOTYPES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 79960266535     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.12.703     Document Type: Article

References (38)

1. Van Rood J.J., Loberiza F.R., Zhang M.J., et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 2002, 99:1572-1577.
2. Fischer A., Durandy A., de Villartay J.P., et al. HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E Rosette fractionation and cyclosporine. Blood 1986, 67:444-449.
3. Lu D.P., Dong L., Wu T., et al. Conditioning including antithymocyte globulin followed by un-manipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes to HLA-identical sibling transplantation. Blood 2006, 107:3065-3073.
4. Chen X.H., Zhang C., Zhang X., et al. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Biol Blood Marrow Transplant 2009, 15:266-273.
5. Guo M., Sun Z., Sun Q.Y., et al. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD. Biol Blood Marrow Transplant 2009, 15:930-937.
6. Spitzer TR. Haploidentical Stem Cell Transplantation: The Always Present but Overlooked Donor. Thomas R. Hematology Am Soc Hematol Educ Program; 2005:390-395.
7. Kolb H.J. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 2008, 112:4371-4383.
8. Satake A., Inoue T., Kubo S., et al. Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells. Int J Hematol 2010, 91:485-497.
9. Symons H.J., Leffell M.S., Rossiter N.D., et al. Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation. Biol Blood Marrow Transplant 2010, 16:533-542.
10. Ciceri F., Labopin M., Aversa F., et al. A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. Blood 2008, 112:3574-3581.
11. Aversa F. Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States. Bone Marrow Transplant 2008, 41:473-481.
12. Pende D., Marcenaro S., Falco M., et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 2009, 113:3119-3129.
13. Wang H.X., Yan H.M., Duan L.N., et al. Haploidentical hematopoietic stem cell transplantation in child hematologic malignancies with G-CSF-mobilized marrow grafts without T-cell depletion: a single-center report of 45 cases. Pediatr Hematol Oncol 2009, 26:119-128.
14. Woolfrey A.E., Gooley T.A., Sievers E.L., et al. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome. Blood 1998, 92:3546-3556.
15. Gonzalez-Vicent M., Perez A., Abad L., et al. Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients. J Pediatr Hematol Oncol 2010, 32:e85-e90.
16. Dong L., Wu T., Zhang M.J., Gao Z.Y., Lu D.P. CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin. Biol Blood Marrow Transplant 2007, 13:1515-1524.
17. Li-Ru Wang, Lu-Jia Dong, Mei-Jie Zhang, Dao-Pei Lu. The impact of human herpesvirus 6b reactivation on early complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant.
18. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
19. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
20. Van Rood J.J. You will never forget your mother!. Blood 2006, 107:7.
21. Cornelissen J.J. Mother and child reunion. Blood 2008, 112:2604-2605.
22. Aversa F., Tabilio A., Terenzi A., et al. Successful engraftment of T-cell-depleted haploidentical " 3-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994, 84:3948-3955.
23. Aversa F., Tabilio A., Velardi A., et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with 1 fully mismatched HLA haplotype. N Engl J Med 1998, 339(17):1186-1193.
24. Handgretinger R., Lang P. The history and future prospective of haplo-identical stem cell transplantation. Cytotherapy 2008, 10:443-451.
25. Kang Y., Chao N.J., Aversa F. Unmanipulated or CD34 selected haplotype mismatched transplants. Curr Opin Hematol 2008, 15:561-567.
26. Reisner Y., Martelli M.F. From " megadose" haploidentical hematopoietic stem cell transplants in acute leukemia to tolerance induction in organ transplantation. Blood Cells Mol Dis 2008, 40:1-7.
27. Heemskerk M.B., vanWalraven S.M., Cornelissen J.J., et al. How to improve the search for an unrelated haematopoietic stemcell donor: faster is better than more. Bone Marrow Transplant 2005, 35:645-652.
28. Stern M., Ruggeri L., Mancusi A., et al. Survival after T cell depleted haploidentical stem cell transplantation is improved using the mother as donor. Blood 2008, 112:2990-2995.
29. Shimazaki C., Ochiai N., Uchida R., et al. Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism. Blood 2003, 101:3334-3336.
30. Yoshihara T., Morimoto A., Inukai T., et al. Non-T-cell-depleted HLA haploidentical stem cell transplantation based on feto-maternal microchimerism in pediatric patients with advanced malignancies. Bone Marrow Transplant 2004, 34:373-375.
31. Ichinohe T., Uchiyama T., Shimazaki C., et al. Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between non-inherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism. Blood 2004, 104:3821-3828.
32. Stern M., de Angelis C., Urbani E., et al. Natural killer-cell KIR repertoire reconstitution after haploidentical SCT. Bone Marrow Transplant 2010, 45:1607-1610.
33. Symons H.J., Leffell M.S., Rossiter N.D., et al. Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation. Biol Blood Marrow Transplant 2010, 16:533-542.
34. Rizzieri D.A., Koh L.P., Long G.D., et al. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. J Clin Oncol 2007, 25:690-697.
35. Koh L.P., Chao N.J. Non-myeloablative allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors: a review. Blood Cells Mol Dis 2008, 40:20-24.
36. Ikegame K., Kawakami M., Yamagami T., et al. HLA-haploidentical nonmyeloablative stem cell transplantation: induction to tolerance without passing through mixed chimaerism. Clin Lab Haematol 2005, 27:139-141.
37. Luznik L., O'Donnell P.V., Symons H.J., et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008, 14:641-650.
38. Symons H.J., Fuchs E.J. Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors. Bone Marrow Transplant 2008, 42:365-377.